TABLE 1.

Demographic and treatment parameters in 6 patients with spinal metastases

Case No.*	Age (yrs)	Sex	Pathology	Tx Region	Tx Dose†	Tx Dates	Follow-Up MRI
1	58	M	Thyroid carcinoma	L-4‡	24 Gy	3/12/2010	1 hr, 61 days, 586 days
2A, B	56	M	Prostate adenocarcinoma	L-2, L-5	24 Gy	10/8/2009	1 hr, 51 days, 839 days
3A, B	52	M	Prostate adenocarcinoma	T-5, T-11	24 Gy	11/10/2009	1 hr, 56 days
4	76	M	Prostate adenocarcinoma	T-10	24 Gy	1/28/2010	1 hr, 57 days, 194 days
5	59	M	Prostate adenocarcinoma	L-3	24 Gy	9/24/2009	1 hr, 504 days
6	57	M	Renal cell carcinoma	L-4	9 Gy (× 3 fractions)	3/12/2012	1 hr, 73 days

Tx = treatment.

^*A and B denote multiple metastases sites for the same patient.

^†For all tumors treated to 24 Gy, the doses were delivered in a single fraction.

^‡Another metastasis, to L-5, occurred later.